Renovascular hypertension: Screening and modern management

Iris Baumgartner, Lilach O Lerman

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The diagnosis and management of patients with renovascular disease and hypertension continue to elude healthcare providers. The advent of novel imaging and interventional techniques, and increased understanding of the pathways leading to irreversible renal injury and renovascular hypertension, have ushered in commendable attempts to optimize and finetune strategies to preserve or restore renal function and control blood pressure. Large randomized clinical trials that compare different forms of therapy, and smaller trials that test novel experimental treatments, will hopefully help formulate innovative concepts and tools to manage the patient population with atherosclerotic renovascular disease.

Original languageEnglish (US)
Pages (from-to)1590-1598
Number of pages9
JournalEuropean Heart Journal
Volume32
Issue number13
DOIs
StatePublished - Jul 2011

Fingerprint

Renovascular Hypertension
Renal Hypertension
Health Personnel
Randomized Controlled Trials
Blood Pressure
Kidney
Wounds and Injuries
Therapeutics
Population

Keywords

  • Atherosclerosis
  • Percutaneous transluminal renal angioplasty
  • Renovascular disease
  • Renovascular hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Renovascular hypertension : Screening and modern management. / Baumgartner, Iris; Lerman, Lilach O.

In: European Heart Journal, Vol. 32, No. 13, 07.2011, p. 1590-1598.

Research output: Contribution to journalArticle

Baumgartner, Iris ; Lerman, Lilach O. / Renovascular hypertension : Screening and modern management. In: European Heart Journal. 2011 ; Vol. 32, No. 13. pp. 1590-1598.
@article{9e76f7e85a804995b75c9fdc919c65f0,
title = "Renovascular hypertension: Screening and modern management",
abstract = "The diagnosis and management of patients with renovascular disease and hypertension continue to elude healthcare providers. The advent of novel imaging and interventional techniques, and increased understanding of the pathways leading to irreversible renal injury and renovascular hypertension, have ushered in commendable attempts to optimize and finetune strategies to preserve or restore renal function and control blood pressure. Large randomized clinical trials that compare different forms of therapy, and smaller trials that test novel experimental treatments, will hopefully help formulate innovative concepts and tools to manage the patient population with atherosclerotic renovascular disease.",
keywords = "Atherosclerosis, Percutaneous transluminal renal angioplasty, Renovascular disease, Renovascular hypertension",
author = "Iris Baumgartner and Lerman, {Lilach O}",
year = "2011",
month = "7",
doi = "10.1093/eurheartj/ehq510",
language = "English (US)",
volume = "32",
pages = "1590--1598",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - Renovascular hypertension

T2 - Screening and modern management

AU - Baumgartner, Iris

AU - Lerman, Lilach O

PY - 2011/7

Y1 - 2011/7

N2 - The diagnosis and management of patients with renovascular disease and hypertension continue to elude healthcare providers. The advent of novel imaging and interventional techniques, and increased understanding of the pathways leading to irreversible renal injury and renovascular hypertension, have ushered in commendable attempts to optimize and finetune strategies to preserve or restore renal function and control blood pressure. Large randomized clinical trials that compare different forms of therapy, and smaller trials that test novel experimental treatments, will hopefully help formulate innovative concepts and tools to manage the patient population with atherosclerotic renovascular disease.

AB - The diagnosis and management of patients with renovascular disease and hypertension continue to elude healthcare providers. The advent of novel imaging and interventional techniques, and increased understanding of the pathways leading to irreversible renal injury and renovascular hypertension, have ushered in commendable attempts to optimize and finetune strategies to preserve or restore renal function and control blood pressure. Large randomized clinical trials that compare different forms of therapy, and smaller trials that test novel experimental treatments, will hopefully help formulate innovative concepts and tools to manage the patient population with atherosclerotic renovascular disease.

KW - Atherosclerosis

KW - Percutaneous transluminal renal angioplasty

KW - Renovascular disease

KW - Renovascular hypertension

UR - http://www.scopus.com/inward/record.url?scp=79959981043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959981043&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehq510

DO - 10.1093/eurheartj/ehq510

M3 - Article

C2 - 21273200

AN - SCOPUS:79959981043

VL - 32

SP - 1590

EP - 1598

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 13

ER -